Is CPHL a Buy? CPHL Smart-Money Analysis, Fair Value & Signal

ZEME verdict — Watching phase

Neutral — no decisive smart-money signal yet; better setups may exist.

What ZEME decides about CPHL, and why

AVOID — earned weight 0 of 1.00, the summed measured record of the backing engines.

Because. 24% above fair value

Risk. stop 58.34 (6.0% below close) — exit there

The case against. against: 24% above fair value

What happens next after the Watching phase

Measured from 582 completed Watching runs in ZEME's recorded phase history — these are frequencies of what actually happened next, not forecasts:

EARLY LOAD — 66.3% of the time (n=386)
LAUNCHING — 10.7% of the time (n=62)
FULLY LOADED — 8.4% of the time (n=49)
EXITED — 5.0% of the time (n=29)
RUNNING — 3.6% of the time (n=21)
WATCH_ONLY — 3.1% of the time (n=18)
LOADING — 1.5% of the time (n=9)
DISTRIBUTING — 1.4% of the time (n=8)

Typical stay in this phase: 4 sessions (median). measured from 2026-07-16

ZEME publishes the case against its own signals, and the base rate any share has to beat. Educational analysis, not investment advice.

Price	Rs 61.66
ZEME fair value	Rs 47.23
Discount to fair value	-23.4%
Smart-money phase	Watching
Confidence score	40/100
RSI (14)	21.5
P/E	17.8
ROE	7.3%
Dividend yield	—%
52-week range	Rs 61.20 – Rs 93.99
Sector	Pharmaceuticals
Shariah-compliant	Yes ☪

✅ Get CPHL signals free — create your ZEME account 📈 Live interactive chart & signals 💬 Ask ZEME about CPHL

CPHL (Citi Pharma Ltd) trades at Rs 61.66 on the Pakistan Stock Exchange, in the Watching smart-money phase — neutral. ZEME's model puts fair value near Rs 47.23, making it about 23.4% overvalued. No decisive smart-money footprint yet — one to watch, not chase.

ZEME AI reads CPHL through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.

Is CPHL a buy right now?

Neutral — no decisive smart-money signal yet; better setups may exist. No decisive smart-money footprint yet — one to watch, not chase. As of 16 Oct 2026, CPHL is in the Watching phase with a ZEME confidence score of 40/100.

What is CPHL's fair value?

ZEME estimates CPHL's fair value at about Rs 47.23, versus a market price of Rs 61.66 — roughly 23.4% overvalued.

What smart-money phase is CPHL in?

CPHL is currently in the Watching phase. No decisive smart-money footprint yet — one to watch, not chase.

More Pharmaceuticals stocks Fundamentals Dividend blue-chips ✓ Track record

Data updated 16 Oct 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.